Decision Diagnostics Corp (DECN)

[cvinvestor]

Past PRs do seem to indicate that they had built some prototypes of the test and validated it, but it would be good to have clear verification of this and what the results were:

]March 16 PR (1 of 4 announced)
“Our product, introduced to the world only 14 days ago has entered its crucial development stage. We are awaiting release of blood samples from previously infected people in Daegu, Korea, so that we can complete testing and make a final report to the U.S. FDA so that we may secure our Emergency Waiver. In the meantime, all other requests made by the FDA will be met this week and next.

This PR's statement from March 18 puts H5N1 ahead of COVID-19 but seems to indicate that they tested the kits against H5N1 and COVID-19.

GenViro!™ has been validated at the company's R&D center in Daegu, Korea for the H5N1 virus and most recently the methodologically similar corona virus.”

March 20 PR
DECN to Finance 2Q 2020 Roll Out of its GenViro! Covid-19 "Rapid" Kits Using Non-Dilutive Debt Financing Totaling $13 Million Acquired in Near 0% Rate Environment